Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A symbols : Clyyf save search
Celyad Oncology announces intention to terminate SEC reporting obligations
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen
Published: 2024-01-25 (Crawled : 22:00) - prnewswire.com
ACLX | $51.67 -5.19% -5.48% 740K
|
|
| O: 0.2%
H: 5.99%
C: 5.65%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
MTEM | $1.455 -2.02% -2.06% 13K
|
Health Technology
|
| O: -2.94%
H: 3.03%
C: 3.03%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.43%
H: 0.27%
C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.66%
H: 0.64%
C: -1.11%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: 1.1%
H: 0.27%
C: -1.64%
companies growth market
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
Published: 2024-01-16 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
business update
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-12-20 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
publication group
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2023-12-15 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
total
Celyad announces management change
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
management change
Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
publication
Publication of a transparency notification
Published: 2023-11-30 (Crawled : 22:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
publication
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-11-21 (Crawled : 21:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
publication group
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2023-11-14 (Crawled : 21:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
total
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
Published: 2023-11-09 (Crawled : 06:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
business financial results
Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026 | North America will account for 40% of the market growth - Technavio
Published: 2023-11-01 (Crawled : 02:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.52%
H: 0.04%
C: 0.04%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -4.18%
H: 0.49%
C: -0.02%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.7%
C: 0.57%
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -2.61%
H: 0.67%
C: 0.67%
america cell therapy growth market
Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026 | Market is driven by the increasing prevalence of chronic disease - Technavio
Published: 2023-10-24 (Crawled : 02:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.4%
H: 1.18%
C: 0.17%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.17%
H: 1.02%
C: 0.4%
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -0.3%
H: 6.21%
C: -8.0%
disease cell therapy market
Celyad Oncology announces the termination of its American Depository Receipt program
Published: 2023-09-25 (Crawled : 20:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
|
| O: 2.01%
H: 0.0%
C: -5.26%
program
Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-09-15 (Crawled : 20:00) - globenewswire.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
publication group
Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-09-12 (Crawled : 20:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
|
| O: -9.27%
H: 0.0%
C: 0.0%
publication
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
Published: 2023-09-07 (Crawled : 20:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
| Email alert
Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
publication group
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2023-09-05 (Crawled : 20:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
|
| O: -10.56%
H: 5.59%
C: -0.62%
total
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
Published: 2023-08-24 (Crawled : 20:00) - celyad.com
CYADY | $0.6 0% 3K
|
n/a
|
| O: -21.51%
H: 27.4%
C: 27.4%
CAR T-Cell Therapy Market size to grow at a CAGR of 13.44% from 2022 to 2027; Growing Awareness Regarding CAR T-cell Therapy to boost the market growth- Technavio.
Published: 2023-08-09 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.14%
H: 0.8%
C: 0.43%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.61%
H: 1.07%
C: -0.5%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -2.02%
H: 3.44%
C: 2.75%
t-cell growing therapy market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.